CardioSignal
CardioSignal develops digital technologies and software-as-medical-devices to provide early detection of heart diseases
CardioSignal has raised €9.2M across 1 funding round from 3 investors, most recently a Series A round in Jan 2024. Based in Turku, Finland; active in Healthtech. Data as of 28 Oct 2026.
Turku, Finlandcardiosignal.com ↗
Total raised
€9.2M
€9,170,105
Funding rounds
1
Investors
3
distinct backers
Active since
2024-01
latest 2024-01
Funding by year
EUR raised per yearCardioSignal — funding by year — interactive chart.
Data table
| CardioSignal — funding by year | |
|---|---|
| 2024 | €9.2M |
Signals
High confidenceRaise-next likelihood21
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-01-24 | Series A | €9.2M | DigiTx Partners,Maki.vc,Sandwater | View deal → |
Investors
3Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData